{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:35:19Z","timestamp":1776839719683,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["structuralheartjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structural Heart"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.shj.2025.100786","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:53:07Z","timestamp":1765612387000},"page":"100786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Anticoagulant Class on Long-Term Bioprosthesis Durability Following Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-4220","authenticated-orcid":false,"given":"Antonin","family":"Trimaille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Vidal-Cales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Hernando Del Portillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3428-617X","authenticated-orcid":false,"given":"Jean-Michel","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-3144","authenticated-orcid":false,"given":"Frederic","family":"Beaupr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Porterie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Salaun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Avvedimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.shj.2025.100786_bib1","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.shj.2025.100786_bib2","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.shj.2025.100786_bib3","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcmg.2018.06.028","article-title":"Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration","volume":"12","author":"Sellers","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.shj.2025.100786_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cvr\/cvac192","article-title":"Aortic stenosis and the hemostatic system","volume":"119","author":"Trimaille","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.shj.2025.100786_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/heartjnl-2017-312861","article-title":"Is bioprosthetic leaflet thrombosis a trigger to valve degeneration?","volume":"104","author":"Doris","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.shj.2025.100786_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.121.058339","article-title":"Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes","volume":"146","author":"Fukui","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.shj.2025.100786_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2024.02.012","article-title":"Human aortic stenotic valve-derived extracellular vesicles induce endothelial dysfunction and thrombogenicity through AT1R\/NADPH Oxidases\/SGLT2 pro-oxidant pathway","volume":"9","author":"Hmadeh","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.shj.2025.100786_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/heartjnl-2017-312514","article-title":"Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement","volume":"104","author":"Del Trigo","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.shj.2025.100786_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2018.08.1045","article-title":"Long-term mortality and early valve dysfunction according to anticoagulation use: the FRANCE TAVI registry","volume":"73","author":"Overtchouk","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jacc.2015.10.097","article-title":"Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: Multicenter registry","volume":"67","author":"Del Trigo","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcin.2024.09.039","article-title":"Hemodynamic valve deterioration after transcatheter aortic valve replacement: incidence, predictors, and clinical outcomes","volume":"18","author":"Alaour","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100786_bib13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2019.01.043","article-title":"Oral anticoagulation therapy and progression of calcific aortic valve stenosis","volume":"73","author":"Tastet","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.118.035150","article-title":"Rate, timing, correlates, and outcomes of hemodynamic valve deterioration after bioprosthetic surgical aortic valve replacement","volume":"138","author":"Salaun","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.shj.2025.100786_bib15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1160\/TH08-09-0611","article-title":"Relation of circulating matrix Gla-protein and anticoagulation status in patients with aortic valve calcification","volume":"101","author":"Koos","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.shj.2025.100786_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.041701","article-title":"Detrimental effect of plasma from patients with severe aortic stenosis on valvular endothelial cells: role of proinflammatory cytokines and factor Xa","author":"Trimaille","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.shj.2025.100786_bib17","first-page":"1048","article-title":"Pathology of balloon-expandable transcatheter aortic valves","volume":"90","author":"Yahagi","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100786_bib18","first-page":"947","article-title":"Pathology of self-expanding transcatheter aortic valves: findings from the CoreValve US pivotal trials","volume":"91","author":"Yahagi","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100786_bib19","article-title":"Pathology of self-expanding transcatheter aortic bioprostheses and hypoattenuated leaflet thickening","volume":"18","author":"Sato","year":"2025","journal-title":"Circ Cardiovasc Interventions"},{"key":"10.1016\/j.shj.2025.100786_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcin.2022.04.018","article-title":"Long-term Follow-Up of hypoattenuated leaflet thickening after transcatheter aortic valve replacement","volume":"15","author":"Hein","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100786_bib21","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.shj.2025.100786_bib22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007411","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"12","author":"Guedeney","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100786_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4075792","article-title":"Incidence and predictors of structural valve deterioration after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"2020","author":"Long","year":"2020","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.shj.2025.100786_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4244\/EIJ-D-19-00710","article-title":"Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves","volume":"15","author":"Rheude","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.shj.2025.100786_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2017.10.027","article-title":"Effects of vitamin K antagonist on aortic valve degeneration in non-valvular atrial fibrillation patients: prospective 4-year observational study","volume":"160","author":"Yamamoto","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.shj.2025.100786_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.shj.2025.100786_bib28","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.shj.2025.100786_bib29","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.shj.2025.100786_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ahj.2025.02.019","article-title":"Clinical outcomes of direct oral anticoagulant versus warfarin after transcatheter aortic valve replacement: from the STS\/ACC TVT registry","volume":"285","author":"Ando","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.shj.2025.100786_bib31","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement: a meta-analysis and trial sequential analysis of randomized trials","volume":"4","author":"Sethi","year":"2025","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.shj.2025.100786_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.041505","article-title":"Transcatheter aortic valve durability: focus on structural valve deterioration","volume":"14","author":"Trimaille","year":"2025","journal-title":"J Am Heart Assoc"}],"container-title":["Structural Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:42:38Z","timestamp":1770842558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2474870625003781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2474870625003781"],"URL":"https:\/\/doi.org\/10.1016\/j.shj.2025.100786","relation":{},"ISSN":["2474-8706"],"issn-type":[{"value":"2474-8706","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Anticoagulant Class on Long-Term Bioprosthesis Durability Following Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"Structural Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.shj.2025.100786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Cardiovascular Research Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100786"}}